Kyowa Hakko Kirin

Results: 49



#Item
21

FOR IMMEDIATE RELEASE February 26, 2014 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of Tokyo) Inquiries: Shigeru Morotomi, Executive Offi

Add to Reading List

Source URL: www.kyowa-kirin.com

Language: English - Date: 2014-02-26 00:10:02
    22

    Kyowa Hakko Kirin Enters Option Agreement with AstraZeneca for Commercialisation of Benralizumab (KHK4563) in Japan Tokyo, Japan, July 16th, 2015—Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai

    Add to Reading List

    Source URL: www.kyowa-kirin.com

    Language: English - Date: 2015-07-21 21:00:16
      23

      Fujifilm Kyowa Kirin Biologics establishes joint venture with AstraZeneca to develop and commercialise anti-VEGF biosimilar July 24, 2015 FUJIFILM Corporation Kyowa Hakko Kirin Co., Ltd. FUJIFILM KYOWA KIRIN BIOLOGICS Co

      Add to Reading List

      Source URL: www.kyowa-kirin.com

      Language: English - Date: 2015-07-24 02:00:04
        24

        FOR IMMEDIATE RELEASE March 10, 2014 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of Tokyo) Inquiries: Shigeru Morotomi, Executive Officer

        Add to Reading List

        Source URL: www.kyowa-kirin.com

        Language: English - Date: 2014-03-10 00:10:04
          25

          Kyowa Hakko Kirin and AstraZeneca Partner on Immuno-Oncology Clinical Study Tokyo, Japan, July 30, Kyowa Hakko Kirin Co., Ltd. (Tokyo; 4151 President and CEO: Nobuo Hanai; "Kyowa Hakko Kirin") announced today th

          Add to Reading List

          Source URL: www.kyowa-kirin.com

          Language: English - Date: 2014-07-30 01:30:04
            26

            Approval of REGPARA® Tablets 12.5mg in Japan Tokyo, Japan, February 16, 2015—Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) announced today that REGPARA® Tablets 12

            Add to Reading List

            Source URL: www.kyowa-kirin.com

            Language: English - Date: 2015-02-16 00:00:17
              27

              Kyowa Hakko Kirin group’s partners Hisamitsu Jazz Pharmaceuticals

              Add to Reading List

              Source URL: www.kyowa-kirin.com

              - Date: 2016-02-02 20:00:15
                28

                FOR IMMEDIATE RELEASE Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of TSE) Inquiries: Shigeru Morotomi, Executive Officer Corporate Commun

                Add to Reading List

                Source URL: www.kyowa-kirin.com

                Language: English - Date: 2015-07-24 02:00:04
                  29

                  January 30, 2015 Kyowa Hakko Kirin Co., Ltd. Appendix to the Consolidated Financial Summary Fiscal 2014

                  Add to Reading List

                  Source URL: www.kyowa-kirin.com

                  Language: English - Date: 2015-01-30 00:40:12
                    30

                    Results Presentation Fiscal 2014 Kyowa Hakko Kirin Co., Ltd. February 2, 2015

                    Add to Reading List

                    Source URL: www.kyowa-kirin.com

                    Language: English - Date: 2015-04-13 22:16:07
                      UPDATE